In patients with PCa [98], as well as with some other urological [99] and non-urological solid tumors such as ovarian cancer [100], hepatocellular cancer [101,102], pancreatic cancer [103,104], and renal cell carcinoma [105], STAT3 overexpression is linked with poor survival. The gene discussed is STAT3; the disease is posterior cortical atrophy.